We Affirm Contention 1 is Psychedelics Barker-16 defines psychedelics as
Psychedelics can also play a pivotal role in the fight against addiction
Download 45.04 Kb.
|
- Navigate this page:
- This effect is proven in other countries that have relaxed their drug laws The DPA-19
- Aside from
- in Portugal
- Contention 2 is Opioid Economics
| Psychedelics can also play a pivotal role in the fight against addiction
Winkelman-14 Michael Winkelman 1 xx, xx-xx-xxxx, "Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca," PubMed, https://pubmed.ncbi.nlm.nih.gov/25563446/ Evidence suggests that the psychedelics have a much greater safety profile than the major addictive drugs, having extremely low levels of mortality, and producing little if any physical dependence. This paper reviews studies evaluating the use of LSD, peyote, ibogaine and ayahuasca in the treatment of dependencies and the possible mechanisms underlying the indications of effectiveness. Evidence suggests that these substances help assist recovery from drug dependency through a variety of therapeutic mechanisms, including a notable "after-glow" effect that in part reflects their action on the serotonin neurotransmitter system. Serotonin has been long recognized as central to the psychedelics' well-known phenomenological, physical, emotional and cognitive dynamics. These serotonin-based dynamics are directly relevant to treatment of addiction because of depressed serotonin levels found in addict populations, as well as the role of serotonin as a neuromodulators affecting many other neurotransmitter systems. This effect is proven in other countries that have relaxed their drug laws The DPA-19 No Author xx, xx-xx-xxxx, "," No Publication, https://drugpolicy.org/sites/default/files/dpa-drug-decriminalization-portugal-health-human-centered-approach_0.pdf Portugal went from having one of the highest rates of problematic drug use in Europe before decriminalization, to having a rate of overall drug consumption that is low in comparison with that of other European countries. Aside from marijuana and new psychoactive substances, drug use for all other drugs has fallen below 2001 levels. Overdose deaths and new cases of HIV and AIDS among people who use drugs have both plummeted since 2001 – a remarkable benefit of Portugal’s decriminalization model. In 2000, people who used drugs accounted for 52 percent of new HIV/AIDS diagnoses (1,430 out of 2,758 cases).10 In 2015, it decreased to a low of 6 percent (77 out of 1,228).11 Since 2001, HIV-related deaths among people who use drugs have consistently fallen. Overdose deaths decreased by over 80 percent after decriminalization.12 In 1999, 369 drug overdose deaths were recorded in Portugal (36.2 per million)13; by 2015 that number had fallen to 54 (5.2 per million).14 Portugal’s drug-induced mortality rate was 5.8 deaths per million in 2015, which is far lower than the European average of 20.3 deaths per million.15 Portugal’s decriminalization model has not led to increases in overall drug use, while it has decisively lowered problematic drug use and improved health outcomes. Contention 2 is Opioid Economics Download 45.04 Kb. Share with your friends:
|